Fetuin-A and Angiopoietins in Obesity and Type 2 Diabetes Mellitus

Overview

Journal Endocrine

Specialty Endocrinology

Date 2012 Jul 24

PMID 22820893

Citations 16

Authors

Sazan Rasul

Ludwig Wagner

Alexandra Kautzky-Willer

Affiliations

Soon will be listed here.

Abstract

Although type 2 diabetes mellitus (DM) is a chronic metabolic disorder with multiple etiologies, obesity has been constantly linked with insulin resistance and manifestation of type 2 DM. In addition, obesity is associated with hypertension, dyslipidemia, and fatty liver disease and is regarded as a subclinical inflammatory condition characterized by release of pro-inflammatory mediators such as cytokines from adipose tissue. Both, type 2 DM and obesity are considered as major risks for developing micro- and macrovascular diseases. Recent studies showed that impaired circulating levels of fetuin-A, which is involved in propagating insulin resistance as well as circulating levels of angiopoietins, which are growth factors promoting angiogenesis, were observed in patients with obesity, metabolic syndrome, and type 2 DM. However, independent of type 2 DM and obesity, defective regulation of fetuin-A and angiopoietin are playing a critical role in predisposing to coronary and peripheral vascular diseases. Therefore, mechanisms linking type 2 DM and obesity with fetuin-A and angiopoietins seem to be complex and are in need of further exploration. In this review, we aimed to present a summary concerning associations of type 2 diabetes, obesity, and vascular diseases with circulating levels of angiopoietins and fetuin-A. Furthermore, we aimed to focus on roles of fetuin-A and angiopoietins and to highlight the most plausible mechanisms that might explain their associations with type 2 DM and obesity.

Citing Articles

Diabetes mellitus and risk of incident dementia in APOE ɛ4 carriers: an updated meta-analysis.

Rashtchian A, Etemadi M, Asadi E, Binaei S, Abbasi M, Bayani M BMC Neurosci. 2024; 25(1):28.

PMID: 38918708 PMC: 11201872. DOI: 10.1186/s12868-024-00878-9.

Distant Metastasis Pattern and Prognostic Prediction Model of Colorectal Cancer Patients Based on Big Data Mining.

Liu C, Wang T, Yang J, Zhang J, Wei S, Guo Y Front Oncol. 2022; 12:878805.

PMID: 35530362 PMC: 9074728. DOI: 10.3389/fonc.2022.878805.

Proteomic Analysis of Aqueous Humor Proteins in Association with Cataract Risks: Diabetes and Smoking.

Chang W, Lee C, Chiou S, Liao C, Cheng C J Clin Med. 2021; 10(24).

PMID: 34945026 PMC: 8703435. DOI: 10.3390/jcm10245731.

Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.

Zhang T, Guo J, Gu J, Wang Z, Wang G, Li H Oncol Rep. 2018; 41(1):279-291.

PMID: 30542696 PMC: 6278419. DOI: 10.3892/or.2018.6840.

Pro-angiogenic Role of Insulin: From Physiology to Pathology.

Escudero C, Herlitz K, Troncoso F, Guevara K, Acurio J, Aguayo C Front Physiol. 2017; 8:204.

PMID: 28424632 PMC: 5380736. DOI: 10.3389/fphys.2017.00204.

References

Weston S, Leyden W, Murphy R, Bass N, Bell B, Manos M . Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease. Hepatology. 2005; 41(2):372-9. DOI: 10.1002/hep.20554. View

Price P, Lim J . The inhibition of calcium phosphate precipitation by fetuin is accompanied by the formation of a fetuin-mineral complex. J Biol Chem. 2003; 278(24):22144-52. DOI: 10.1074/jbc.M300744200. View

Hajer G, van Haeften T, Visseren F . Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J. 2008; 29(24):2959-71. DOI: 10.1093/eurheartj/ehn387. View

Heiss A, DuChesne A, Denecke B, Grotzinger J, Yamamoto K, Renne T . Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles. J Biol Chem. 2003; 278(15):13333-41. DOI: 10.1074/jbc.M210868200. View

Stefan N, Hennige A, Staiger H, Machann J, Schick F, Krober S . Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care. 2006; 29(4):853-7. DOI: 10.2337/diacare.29.04.06.dc05-1938. View

Su D, Zhang N, He J, Qu S, Slusher S, Bottino R . Angiopoietin-1 production in islets improves islet engraftment and protects islets from cytokine-induced apoptosis. Diabetes. 2007; 56(9):2274-83. DOI: 10.2337/db07-0371. View

Ishibashi A, Ikeda Y, Ohguro T, Kumon Y, Yamanaka S, Takata H . Serum fetuin-A is an independent marker of insulin resistance in Japanese men. J Atheroscler Thromb. 2010; 17(9):925-33. DOI: 10.5551/jat.3830. View

Brix J, Stingl H, Hollerl F, Schernthaner G, Kopp H, Schernthaner G . Elevated Fetuin-A concentrations in morbid obesity decrease after dramatic weight loss. J Clin Endocrinol Metab. 2010; 95(11):4877-81. DOI: 10.1210/jc.2010-0148. View

Lindsey J, Cipollone F, Abdullah S, McGuire D . Receptor for advanced glycation end-products (RAGE) and soluble RAGE (sRAGE): cardiovascular implications. Diab Vasc Dis Res. 2009; 6(1):7-14. DOI: 10.3132/dvdr.2009.002. View

10.

Rodriguez A, Catalan V, Gomez-Ambrosi J, Fruhbeck G . Visceral and subcutaneous adiposity: are both potential therapeutic targets for tackling the metabolic syndrome?. Curr Pharm Des. 2007; 13(21):2169-75. DOI: 10.2174/138161207781039599. View

11.

Yamamoto Y, Kato I, Doi T, Yonekura H, Ohashi S, Takeuchi M . Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice. J Clin Invest. 2001; 108(2):261-8. PMC: 203021. DOI: 10.1172/JCI11771. View

12.

Rasul S, Ilhan A, Reiter M, Baumgartner-Parzer S, Kautzky-Willer A . Relations of adiponectin to levels of metabolic parameters and sexual hormones in elderly type 2 diabetic patients. Gend Med. 2011; 8(2):93-102. DOI: 10.1016/j.genm.2011.01.004. View

13.

Kern P, Di Gregorio G, Lu T, Rassouli N, Ranganathan G . Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes. 2003; 52(7):1779-85. DOI: 10.2337/diabetes.52.7.1779. View

14.

Kirkpantur A, Altun B, Hazirolan T, Akata D, Arici M, Kirazli S . Association among serum fetuin-A level, coronary artery calcification, and bone mineral densitometry in maintenance hemodialysis patients. Artif Organs. 2009; 33(10):844-54. DOI: 10.1111/j.1525-1594.2009.00814.x. View

15.

Tuo Q, Zeng H, Stinnett A, Yu H, Aschner J, Liao D . Critical role of angiopoietins/Tie-2 in hyperglycemic exacerbation of myocardial infarction and impaired angiogenesis. Am J Physiol Heart Circ Physiol. 2008; 294(6):H2547-57. DOI: 10.1152/ajpheart.01250.2007. View

16.

Haukeland J, Dahl T, Yndestad A, Gladhaug I, Loberg E, Haaland T . Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies. Eur J Endocrinol. 2011; 166(3):503-10. DOI: 10.1530/EJE-11-0864. View

17.

Kotronen A, Yki-Jarvinen H . Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2007; 28(1):27-38. DOI: 10.1161/ATVBAHA.107.147538. View

18.

Mohamed-Ali V, Pinkney J, Coppack S . Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord. 1999; 22(12):1145-58. DOI: 10.1038/sj.ijo.0800770. View

19.

Kampfer H, Pfeilschifter J, Frank S . Expressional regulation of angiopoietin-1 and -2 and the tie-1 and -2 receptor tyrosine kinases during cutaneous wound healing: a comparative study of normal and impaired repair. Lab Invest. 2001; 81(3):361-73. DOI: 10.1038/labinvest.3780244. View

20.

Ferreira D, Castro R, Machado M, Evangelista T, Silvestre A, Costa A . Apoptosis and insulin resistance in liver and peripheral tissues of morbidly obese patients is associated with different stages of non-alcoholic fatty liver disease. Diabetologia. 2011; 54(7):1788-98. DOI: 10.1007/s00125-011-2130-8. View